K Number
K093680
Date Cleared
2010-04-08

(132 days)

Product Code
Regulation Number
862.1225
Panel
CH
Reference & Predicate Devices
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Diazyme Cystatin C Assay is an in-vitro diagnostic test for the quantitative determination of Cystatin C in serum or plasma by latex enhanced immunoturbidimetric method. The measurement of Cystatin C is used as an aid in the diagnosis and treatment of renal disease.

Device Description

Not Found

AI/ML Overview

The provided document is a 510(k) clearance letter for the Diazyme Cystatin C Assay. It states that the device is substantially equivalent to legally marketed predicate devices. However, this document does not contain the detailed study information, acceptance criteria, or performance data typically found in a 510(k) summary or the full submission.

Therefore, I cannot provide a complete answer to your request based solely on the provided text. The document confirms the device's purpose as an in-vitro diagnostic test for Cystatin C to aid in the diagnosis and treatment of renal disease, but it lacks the specific performance data you are asking for.

To answer your questions, I would need access to the 510(k) summary (which usually includes performance data) or the full 510(k) submission for K093680.

§ 862.1225 Creatinine test system.

(a)
Identification. A creatinine test system is a device intended to measure creatinine levels in plasma and urine. Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis, and as a calculation basis for measuring other urine analytes.(b)
Classification. Class II.